Addex Therapeutics (ADXN) Enterprise Value (2022 - 2025)
Historic Enterprise Value for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to -$2.7 million.
- Addex Therapeutics' Enterprise Value fell 4790732.56% to -$2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 million, marking a year-over-year decrease of 4790732.56%. This contributed to the annual value of -$3.8 million for FY2024, which is 1159.12% up from last year.
- Addex Therapeutics' Enterprise Value amounted to -$2.7 million in Q3 2025, which was down 4790732.56% from -$4.0 million recorded in Q2 2025.
- Over the past 5 years, Addex Therapeutics' Enterprise Value peaked at -$490.17 during Q3 2023, and registered a low of -$22.2 million during Q1 2022.
- In the last 4 years, Addex Therapeutics' Enterprise Value had a median value of -$4.0 million in 2025 and averaged -$6.8 million.
- As far as peak fluctuations go, Addex Therapeutics' Enterprise Value soared by 9999.77% in 2023, and later plummeted by 11524471.75% in 2025.
- Addex Therapeutics' Enterprise Value (Quarter) stood at -$7.2 million in 2022, then surged by 39.67% to -$4.4 million in 2023, then rose by 12.31% to -$3.8 million in 2024, then grew by 28.24% to -$2.7 million in 2025.
- Its Enterprise Value stands at -$2.7 million for Q3 2025, versus -$4.0 million for Q2 2025 and -$3.2 million for Q1 2025.